Marriage Counselors in North Kingstown, RI Accepting Medicare

6 Marriage Counselors found. Showing 1 - 6

Linda Cloutier, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 650 Ten Rod Rd Unit 13, Family Serivce Of Rhode Island, North Kingstown, RI 02852 Phone: 401-331-1350    Fax: 401-277-3366

Jody Eyre, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 650 Ten Rod Rd Unit 13, C/o Family Service Of Rhode Island, North Kingstown, RI 02852 Phone: 401-331-1350    Fax: 401-277-3366

Tiffany Lee Kaelin, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1130 Ten Rod Rd Ste E305, North Kingstown, RI 02852 Phone: 401-294-0451

Mrs. Jennifer Susan Wilkinson Shepherd, M.S. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1130 Ten Rod Rd, Bldg F Box 16, North Kingstown, RI 02852 Phone: 401-368-6622    Fax: 401-294-4540

Ms. Margaret M Webb, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1130 Ten Rod Rd, C-206, North Kingstown, RI 02852 Phone: 401-294-1120

Karen E Kershaw, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 650 Ten Rod Rd Unit 13, C/o Family Service Of Rhode Island, Inc, North Kingstown, RI 02852 Phone: 401-331-1350    Fax: 401-277-3366

News Archive

States encouraged to use Medicaid expansion money to buy private insurance for poor

The New York Times reports that the White House is encouraging skeptical state officials to expand Medicaid by using federal money to subsidize the purchase of private insurance for low-income people - a model not envisioned by drafters of the law.

New study finds PEM reduces unnecessary breast biopsies

The Radiology journal released new data from an NIH-sponsored, multi-site study of hundreds of women with newly diagnosed breast cancer that shows Positron Emission Mammography (PEM) may reduce unnecessary breast biopsies. The study found that PEM was significantly more precise at identifying benign and cancerous lesions, in what scientists call "Positive Predictive Value" or "PPV," therefore reducing the number of unnecessary biopsies.

SQI Diagnostics signs development agreement with Silliker

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that it has entered into a development agreement with Silliker, Inc., a leading internationally accredited company dedicated to improving nutrition, food safety and quality, for the commercialization of a botulism toxin panel that will run on SQI's SQiDman analytical system.

Aripiprazole has potential for treating alcohol dependence

Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. Future research will need to examine the beneficial versus the side effects of aripiprazole for treatment of alcohol dependence.

First patient enrolled in phase III study of Bevacizumab and Trastuzumab in early breast cancer

A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.

Read more Medical News

› Verified 6 days ago